These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 14391838

  • 21. Renal amyloidosis (part I).
    Ferrario F, Rastaldi MP.
    J Nephrol; 2006; 19(2):123-5. PubMed ID: 16736407
    [Abstract] [Full Text] [Related]

  • 22. Mucocutaneous bullous amyloidosis with an unusual mixed protein composition of amyloid deposits.
    Rekhtman N, Hash KS, Moresi JM.
    Br J Dermatol; 2006 Apr; 154(4):751-4. PubMed ID: 16536823
    [Abstract] [Full Text] [Related]

  • 23. Role of conformational change in the C-terminus of beta2-microglobulin in dialysis-related amyloidosis.
    Kim J, Motomiya Y, Ueda M, Nakamura M, Misumi Y, Saito S, Ikemizu S, Misumi S, Ota K, Shinriki S, Kai H, Ando Y.
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):489-95. PubMed ID: 18753422
    [Abstract] [Full Text] [Related]

  • 24. [Endocrine glands and liver function; effect of parathyroid extract on amino acid curve produced by glycocoll in normal subjects and in liver insufficiency].
    MORGANO G, ASSERETO G.
    Arch Maragliano Patol Clin; 1953 Sep; 8(5):1141-7. PubMed ID: 13125776
    [No Abstract] [Full Text] [Related]

  • 25. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC.
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [Abstract] [Full Text] [Related]

  • 26. Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis.
    Saito S, Ando Y, Nakamura M, Ueda M, Kim J, Ishima Y, Akaike T, Otagiri M.
    Biochemistry; 2005 Aug 23; 44(33):11122-9. PubMed ID: 16101296
    [Abstract] [Full Text] [Related]

  • 27. An animal model of vascular amyloidosis.
    Ghiso J, Wisniewski T.
    Nat Neurosci; 2004 Sep 23; 7(9):902-4. PubMed ID: 15332087
    [No Abstract] [Full Text] [Related]

  • 28. Colocalization of apolipoprotein AI in various kinds of systemic amyloidosis.
    Sakata N, Hoshii Y, Nakamura T, Kiyama M, Arai H, Omoto M, Morimatsu M, Ishihara T.
    J Histochem Cytochem; 2005 Feb 23; 53(2):237-42. PubMed ID: 15684336
    [Abstract] [Full Text] [Related]

  • 29. [Conformational and intermolecular interactions of proteins in amyloidosis].
    Mal'tsev AV, Kaminskiĭ IuG, Il'iasov FE, Rozanova NA, Fediukin VS, Baĭramov VM.
    Biofizika; 2005 Feb 23; 50(3):470-4. PubMed ID: 15977837
    [Abstract] [Full Text] [Related]

  • 30. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
    Sørby R, Espenes A, Landsverk T, Westermark G.
    Amyloid; 2008 Mar 23; 15(1):20-8. PubMed ID: 18266118
    [Abstract] [Full Text] [Related]

  • 31. Alpha-sheet: The toxic conformer in amyloid diseases?
    Daggett V.
    Acc Chem Res; 2006 Sep 23; 39(9):594-602. PubMed ID: 16981675
    [Abstract] [Full Text] [Related]

  • 32. Shedding light on amyloidosis with protein engineering.
    Daggett V.
    Protein Eng Des Sel; 2009 Aug 23; 22(8):445. PubMed ID: 19648355
    [No Abstract] [Full Text] [Related]

  • 33. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
    Bergström J, Gustavsson A, Hellman U, Sletten K, Murphy CL, Weiss DT, Solomon A, Olofsson BO, Westermark P.
    J Pathol; 2005 Jun 23; 206(2):224-32. PubMed ID: 15810051
    [Abstract] [Full Text] [Related]

  • 34. Additional evidence that the fibril amyloid-related proteins share local regions of amino acid sequence similarity.
    Benvenga S, Guarneri F.
    Amyloid; 2008 Dec 23; 15(4):269-71. PubMed ID: 19065299
    [No Abstract] [Full Text] [Related]

  • 35. Deposition diseases and 3D domain swapping.
    Bennett MJ, Sawaya MR, Eisenberg D.
    Structure; 2006 May 23; 14(5):811-24. PubMed ID: 16698543
    [Abstract] [Full Text] [Related]

  • 36. Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis.
    Ueda M, Ando Y, Haraoka K, Katsuragi S, Terasaki Y, Sugimoto M, Sun X, Uchino M.
    Amyloid; 2006 Mar 23; 13(1):24-30. PubMed ID: 16690497
    [Abstract] [Full Text] [Related]

  • 37. Amyloidosis of pancreatic islets in primary amyloidosis (AL type).
    Tomita T.
    Pathol Int; 2005 Apr 23; 55(4):223-7. PubMed ID: 15826250
    [Abstract] [Full Text] [Related]

  • 38. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases.
    Pawar AP, Dubay KF, Zurdo J, Chiti F, Vendruscolo M, Dobson CM.
    J Mol Biol; 2005 Jul 08; 350(2):379-92. PubMed ID: 15925383
    [Abstract] [Full Text] [Related]

  • 39. [What causes Abeta amyloidosis in the brain?].
    Matsubara E, Yanagisawa K.
    No To Shinkei; 2005 Oct 08; 57(10):829-38. PubMed ID: 16277228
    [No Abstract] [Full Text] [Related]

  • 40. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
    Green NS, Palaninathan SK, Sacchettini JC, Kelly JW.
    J Am Chem Soc; 2003 Nov 05; 125(44):13404-14. PubMed ID: 14583036
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.